WFMPM
UTMD icon

Woodley Farra Manion Portfolio Management’s Utah Medical Products UTMD Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-57
Closed -$5K – 378
2020
Q2 		$5K Hold
57
– – ﹤0.01% 332
2020
Q1 		$5K Hold
57
– – ﹤0.01% 323
2019
Q4 		$6K Buy
+57
New +$5.78K ﹤0.01% 311

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's UTMD Position: Q3 2020 in Review

Woodley Farra Manion Portfolio Management sold out of Utah Medical Products (UTMD) in Q3 2020, closing a stake of 57 shares — an estimated $5K sold.

Woodley Farra Manion Portfolio Management first reported a position in UTMD in Q4 2019 and held it in 3 quarters. The position peaked at $6K in Q4 2019. 85 funds tracked by Wall St. Rank hold UTMD as of Q3 2020.

  • Woodley Farra Manion Portfolio Management reported no remaining Utah Medical Products position as of Q3 2020 after selling out during the quarter.
  • Woodley Farra Manion Portfolio Management sold 57 Utah Medical Products shares in Q3 2020, an estimated $5K.
  • Woodley Farra Manion Portfolio Management first reported a position in Utah Medical Products in Q4 2019 and held it in 3 quarters.
  • Woodley Farra Manion Portfolio Management's Utah Medical Products position peaked at $6K in Q4 2019.
  • 85 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2020.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q3 2020, filed 5 Nov 2020.